Tin tức & Cập nhật

Novel drug helps optimize HFrEF therapy
Novel drug helps optimize HFrEF therapy
27 Apr 2022 bởiAudrey Abella

In individuals receiving renin-angiotensin-aldosterone system inhibitor (RAASi) therapy for heart failure with reduced ejection fraction (HFrEF), the novel potassium binder patiromer effectively reduced serum potassium levels, the DIAMOND trial suggests, thus optimizing a guideline-directed RAASi therapy for these patients.

Novel drug helps optimize HFrEF therapy
27 Apr 2022
Cardiac deaths, neurologic injuries, multiorgan failures account for most AMICS deaths
Cardiac deaths, neurologic injuries, multiorgan failures account for most AMICS deaths
25 Apr 2022

The primary causes of death in patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) are heart failure, neurologic injury, and multiorgan failure (MOF), reports a recent study. Deaths from cardiac causes often occur within 13 hours of the first medical contact.

Cardiac deaths, neurologic injuries, multiorgan failures account for most AMICS deaths
25 Apr 2022
Infertility ups risk of heart failure in women
Infertility ups risk of heart failure in women
25 Apr 2022

A history of infertility among women appears to contribute to an increased risk of incident heart failure (HF), reveals a recent study.

Infertility ups risk of heart failure in women
25 Apr 2022
Pandemic-related delays in thrombolysis worsens outcomes
Pandemic-related delays in thrombolysis worsens outcomes
25 Apr 2022 bởiTristan Manalac

Patients who have had to delay their intravenous thrombolysis (IVT) procedures due to the COVID-19 pandemic suffer from worse short-term clinical outcomes such as higher rates of mortality and hospice care, reports a study presented at the Annual Meeting of the American Academy of Neurology (AAN 2022). These patients are also less likely to be discharged to their homes or to rehabilitation facilities.

Pandemic-related delays in thrombolysis worsens outcomes
25 Apr 2022